Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats

Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance

(2016) D. J. Reiner et al.   JOURNAL OF NEUROSCIENCE

Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways

(2016) Imre Farkas et al.   Frontiers in Cellular Neuroscience

Treatment of Obesity in 2015

(2015) Alpana P. Shukla et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine

(2015) Heath D Schmidt et al.   NEUROPSYCHOPHARMACOLOGY

Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior

(2015) Anne E Harasta et al.   NEUROPSYCHOPHARMACOLOGY

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice

(2015) Gunnar Sørensen et al.   PHYSIOLOGY & BEHAVIOR

Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A

(2015) Sindhu Rajan et al.   Molecular Metabolism

Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance

(2015) Sri Harsha Tella et al.   Therapeutic Advances in Endocrinology and Metabolism

The GLP-1 Receptor Agonist Exendin-4 and Diazepam Differentially Regulate GABAA Receptor-Mediated Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons

(2015) Sergiy V. Korol et al.   PLoS One

Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy

(2014) Jörgen A. Engel et al.   CNS DRUGS

GLP-1 and Exendin-4 Transiently Enhance GABAAReceptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons

(2014) Sergiy V. Korol et al.   DIABETES

ADAR2-dependent GluA2 editing regulates cocaine seeking

(2014) H D Schmidt et al.   MOLECULAR PSYCHIATRY

The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors

(2013) Elizabeth G. Mietlicki-Baase et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice

(2013) Emil Egecioglu et al.   PLoS One

The central GLP-1: implications for food and drug reward

(2013) Karolina P. Skibicka   Frontiers in Neuroscience

Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance

(2012) Harvey J. Grill et al.   Cell Metabolism

The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors

(2012) S. L. Dickson et al.   JOURNAL OF NEUROSCIENCE

GLP-1 analog attenuates cocaine reward

(2012) D L Graham et al.   MOLECULAR PSYCHIATRY

The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction

(2012) Ralph J DiLeone et al.   NATURE NEUROSCIENCE

Obesity and addiction: neurobiological overlaps

(2012) N. D. Volkow et al.   Obesity Reviews

Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation

(2011) Matthew R. Hayes et al.   Cell Metabolism

GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake

(2011) Amber L. Alhadeff et al.   ENDOCRINOLOGY

Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function

(2011) J. G. Barrera et al.   JOURNAL OF NEUROSCIENCE

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

(2011) Scott E. Kanoski et al.   NEUROPHARMACOLOGY

Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats

(2011) Matthew R. Hayes et al.   Obesity

Cocaine-induced neuroadaptations in glutamate transmission

(2010) Heath D. Schmidt et al.   Annals of the New York Academy of Sciences

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

(2009) John B Buse et al.   LANCET

Incretin-based therapies for type 2 diabetes mellitus

(2009) Julie A. Lovshin et al.   Nature Reviews Endocrinology